The US FDA has granted fast track designation to Artiva Biotherapeutics’ AlloNK plus rituximab or obinutuzumab, for the treatment of lupus nephritis (LN).
Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in Lupus Nephritis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Easier Access to NK-Based Cell Therapies genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Danish brand OYOY Living Design is continuing its mission to create furniture and objects for the family home with its new Togetherness Award and the winners will be announced at the London Design Fair.
The US Food and Drug Administration (FDA) has granted fast track designation to clinical stage company Artiva Biotherapeutics’s lead programme AB-101.